-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Maintains Overweight on Ardent Health, Raises Price Target to $21

Benzinga·11/06/2026 20:43:53
Listen to the news
Stephens & Co. analyst Scott Fidel maintains Ardent Health (NYSE:ARDT) with a Overweight and raises the price target from $13 to $21.